Country for PR: United States
Contributor: PR Newswire New York
Monday, April 15 2019 - 06:00
AsiaNet
Stryker Launches Next Generation Flow Diverter for Treatment of Brain Aneurysms
KALAMAZOO, Michigan, USA, Apr. 15, 2019 /PRNewswire-AsiaNet/--

Stryker announces the availability of the Surpass Evolve Flow Diverter 
following CE mark approval in March. Surpass Evolve is Stryker's latest entrant 
into the flow diversion space for the treatment of brain aneurysms. 

Photo - 
https://mma.prnewswire.com/media/871072/Surpass_Evolve_Flow_Diverter_Image.jpg 

Building on the reliable opening and optimal flow diversion profile of the 
existing Surpass platform, this new device has been designed to maximize 
overall procedural ease of use and provide physicians with a high level of 
control through the procedure. "The Surpass Evolve Flow Diverter is the 
culmination of many years of flow diversion research, extensive physician 
feedback from around the world and Stryker engineering prowess. This high 
performing device will be a great addition to our hemorrhagic portfolio to help 
physicians in the treatment of brain aneurysms," said Mark Paul, President, 
Stryker's Neurovascular Division.

"Surpass Evolve represents a breakthrough advancement in the treatment of 
complex brain aneurysms. The device is easy to use, highly responsive and 
demonstrates a strong flow diversion for aneurysm healing," stated Dr. Vitor 
Mendes Pereira, Professor at Toronto Western Hospital, who conducted the first 
clinical procedures.

Usage of flow diversion technology for the treatment of brain aneurysms has 
grown in acceptance and significant over the last decade. Flow diverters enable 
physicians to treat their patients suffering from brain aneurysms without ever 
entering the sac of the aneurysm itself. 

About brain aneurysms and flow diverters

An aneurysm occurs when a part of a blood vessel becomes weak, causing the 
vessel to balloon or bulge and fill with blood. Aneurysms can occur in any 
blood vessel in the body. However, brain aneurysms are the most 
life-threatening. If left untreated, the aneurysm may continue to weaken until 
it bursts and bleeds into the brain. Almost 500,000 deaths occur each year as a 
result of a brain aneurysm. 

About Stryker

Stryker is one of the world's leading medical technology companies and, 
together with its customers, is driven to make healthcare better. The company 
offers innovative products and services in Orthopaedics, Medical and Surgical, 
and Neurotechnology and Spine that help improve patient and hospital outcomes. 
More information is available at www.stryker.com.

Media contact: 
Keri Laden 
Stryker 
keri.laden@stryker.com

SOURCE: Stryker